Menopause as a Regulatory Phase Transition: A Systems-Level View of Hormonal Withdrawal, Allostatic Load, and Adaptive Capacity

Menopause is commonly framed as a hormonal deficiency state characterised by oestrogen loss and its downstream symptoms. While endocrine changes are central, this framing fails to explain the marked variability in menopausal experience, the clustering of systemic symptoms, and the persistence of dysregulation in some individuals long after hormonal stabilisation. This paper proposes a systems-level reframing of menopause as a regulatory phase transition in which the withdrawal of ovarian hormones unmasks pre-existing allostatic load across neuroendocrine, metabolic, immune, and stress-regulatory systems. Within this framework, menopausal symptoms are not isolated pathologies but emergent signals of reduced buffering capacity and altered recovery dynamics. Ovarian hormones are described as distributed stabilisers rather than isolated controllers, preserving adaptive margin across stress responsivity, immune tone, metabolic flexibility, and neural plasticity during the reproductive lifespan. Their withdrawal redistributes regulatory demand onto remaining buffering systems, most notably the endocannabinoid system (ECS), which is positioned as a secondary containment network whose role becomes increasingly visible under conditions of elevated baseline load. This model explains symptom clustering, inter-individual variability, and persistence beyond endocrine stabilisation without invoking pathology, moral attribution, or hormone determinism. Post-menopausal outcomes are shown to diverge based on recovery feasibility rather than hormonal change itself. The analysis is explicitly descriptive and non-prescriptive. It proposes no treatments, diagnostic criteria, or clinical pathways. Instead, it provides a load-aware systems biology framework for understanding menopause as a predictable regulatory transition governed by adaptive capacity rather than failure.